SlideShare a Scribd company logo
Pharmacology
Pharmacology
Pharmacology
Drugs That Affect The:
Nervous System
Drugs That Affect The:
Nervous System
Topics
Topics
Topics
• Analgesics and antagonists
• Anesthetics
• Anti-anxiety and sedative-hypnotics
• Anti-seizure / anti-convulsants
• CNS stimulators
• Psychotherapeutics
• ANS/PNS/SNS agents
• Analgesics and antagonists
• Anesthetics
• Anti-anxiety and sedative-hypnotics
• Anti-seizure / anti-convulsants
• CNS stimulators
• Psychotherapeutics
• ANS/PNS/SNS agents
A colorful review of
neurophysiology!
A colorful review of
neurophysiology!
But first...
But first...
But first...
Nervous System
Nervous System
Nervous System
CNS
CNS PNS
PNS
Somatic
Somatic
Autonomic
Autonomic
Parasympathetic
Parasympathetic
Sympathetic
Sympathetic
Analgesics
Analgesics
Analgesics
• Decrease in sensation of pain.
• Classes:
– Opioid.
• Agonist.
• Antagonist.
• Agonist-antagonist.
– Non-opioids.
• Salicylates.
• NSAIDs.
• Adjuncts.
• Decrease in sensation of pain.
• Classes:
– Opioid.
• Agonist.
• Antagonist.
• Agonist-antagonist.
– Non-opioids.
• Salicylates.
• NSAIDs.
• Adjuncts.
Opioids
Opioids
Opioids
• Generic reference to
morphine-like
drugs/actions
– Opiate: derivative of opium
• Prototype: morphine
– Morpheus: god of dreams
• Act on endorphin
receptors:
– Mu (most important)
– Kappa
• Generic reference to
morphine-like
drugs/actions
– Opiate: derivative of opium
• Prototype: morphine
– Morpheus: god of dreams
• Act on endorphin
receptors:
– Mu (most important)
– Kappa
Actions of Opioid Receptors
Actions of Opioid Receptors
Actions of Opioid Receptors
Response Mu Kappa
Analgesia ; ;
Respiratory
Depression
;
Sedation ; ;
Euphoria ;
Physical Dependence ;
⇓ GI motility ; ;
Actions at Opioid Receptors
Actions at Opioid Receptors
Actions at Opioid Receptors
Drugs Mu Kappa
Pure Agonists
-morphine, codeine, meperidine (Demerol®),
fentanyl (Sublimaze®), remifentanil (Ultiva®),
propoxyphene (Darvon®), hydrocodone (Vicodin®),
oxycodone (Percocet®)
Agonist Agonist
Agonist-Antagonist
-nalbuphine (Nubaine®), butorphanol (Stadol®)
Antagonist Agonist
Pure Antagonist
-naloxone (Narcan®)
Antagonist Antagonist
General Actions of Opioids
General Actions of Opioids
General Actions of Opioids
• Analgesia
• Respiratory depression
• Constipation
• Urinary retention
• Cough suppression
• Emesis
• Increased ICP
– Indirect through CO2
retention
• Analgesia
• Respiratory depression
• Constipation
• Urinary retention
• Cough suppression
• Emesis
• Increased ICP
– Indirect through CO2
retention
• Euphoria/Dysphoria
• Sedation
• Miosis
– Pupil constriction
• ⇓ Preload & afterload
– Watch for
hypotension!
• Euphoria/Dysphoria
• Sedation
• Miosis
– Pupil constriction
• ⇓ Preload & afterload
– Watch for
hypotension!
Non-opioid Analgesics
Non
Non-
-opioid
opioid Analgesics
Analgesics
• Salicylates
– Aspirin (Bayer® ) * (prototype for class)
• Non-Steroidal Anti-Inflammatory Drugs
• Ibuprofen (Motrin®, Advil®)
– Propionic Acid derivative
• Naproxen (Naprosyn®)
• Naproxen sodium (Aleve®)
• All compete with aspirin for protein binding sites
– Ketorolac (Toradol®)
• Salicylates
– Aspirin (Bayer® ) * (prototype for class)
• Non-Steroidal Anti-Inflammatory Drugs
• Ibuprofen (Motrin®, Advil®)
– Propionic Acid derivative
• Naproxen (Naprosyn®)
• Naproxen sodium (Aleve®)
• All compete with aspirin for protein binding sites
– Ketorolac (Toradol®)
NSAID Properties
NSAID Properties
NSAID Properties
Drug Fever Inflammation Pain
Aspirin ; ; ;
Ibuprofen ; ; ;
Acetaminophen ; ;
Aspirin Mechanism of Action
Aspirin Mechanism of Action
Aspirin Mechanism of Action
• Inhibit synthesis of cyclooxygenase (COX)
– Enzyme responsible for synthesis of:
• Inhibit synthesis of cyclooxygenase (COX)
– Enzyme responsible for synthesis of:
Prostaglandins
–Pain response
–Suppression of gastric acid secretion
–Promote secretion of gastric mucus and bicarbonate
–Mediation of inflammatory response
–Production of fever
–Promote renal vasodilation (⇑ blood flow)
–Promote uterine contraction
Prostaglandins
–Pain response
–Suppression of gastric acid secretion
–Promote secretion of gastric mucus and bicarbonate
–Mediation of inflammatory response
–Production of fever
–Promote renal vasodilation (⇑ blood flow)
–Promote uterine contraction
Thromboxane A2
–Involved in platelet
–aggregation
Thromboxane A2
–Involved in platelet
–aggregation
Aspirin Effects
Aspirin Effects
Aspirin Effects
Good
• Pain relief
• ⇓ Fever
• ⇓ Inflammation
Good
• Pain relief
• ⇓ Fever
• ⇓ Inflammation
Bad
• GI ulceration:
– ⇑ Gastric acidity
– ⇓ GI protection
• ⇑ Bleeding
• ⇓ Renal elimination
• ⇓ Uterine contractions
during labor
Bad
• GI ulceration:
– ⇑ Gastric acidity
– ⇓ GI protection
• ⇑ Bleeding
• ⇓ Renal elimination
• ⇓ Uterine contractions
during labor
Acetaminophen (Tylenol®)
Acetaminophen (Tylenol
Acetaminophen (Tylenol®
®
)
)
• NSAID similar to aspirin
• Only inhibits synthesis of CNS
prostaglandins
– Does not have peripheral side effects of ASA:
• Gastric ulceration
• ⇓ Platelet aggregation
• ⇓ Renal flow
• ⇓ Uterine contractions
• NSAID similar to aspirin
• Only inhibits synthesis of CNS
prostaglandins
– Does not have peripheral side effects of ASA:
• Gastric ulceration
• ⇓ Platelet aggregation
• ⇓ Renal flow
• ⇓ Uterine contractions
Acetaminophen Metabolism
Acetaminophen Metabolism
Acetaminophen Metabolism
Acetaminophen
Acetaminophen Non-toxic
metabolites
Non-toxic
metabolites
Major Pathway
Minor Pathway
P-450
Toxic
metabolites
Toxic
metabolites
Non-toxic
metabolites
Non-toxic
metabolites
Induced by
ETOH
Induced by
ETOH
Glutathione
Depleted by ETOH &
APAP overdose
Depleted by ETOH &
APAP overdose
Anesthetics
Anesthetics
Anesthetics
• Loss of all sensation
– Usually with loss of consciousness
– ⇓ propagation of neural impulses
• General anesthetics
– Gases
• Nitrous oxide (Nitronox®), halothane, ether
– IV
• Thiopental (Pentothal®), methohexital (Brevitol®),
diazepam (valium®), remifentanil (Ultiva®)
• Loss of all sensation
– Usually with loss of consciousness
– ⇓ propagation of neural impulses
• General anesthetics
– Gases
• Nitrous oxide (Nitronox®), halothane, ether
– IV
• Thiopental (Pentothal®), methohexital (Brevitol®),
diazepam (valium®), remifentanil (Ultiva®)
Anesthetics
Anesthetics
Anesthetics
• Local
– Affect on area around injection
– Usually accompanied by epinephrine
• Lidocaine (Xylocaine ®), topical cocaine
• Local
– Affect on area around injection
– Usually accompanied by epinephrine
• Lidocaine (Xylocaine ®), topical cocaine
Anti-anxiety & Sedative-
hypnotic Drugs
Anti
Anti-
-anxiety & Sedative
anxiety & Sedative-
-
hypnotic Drugs
hypnotic Drugs
• Sedation: ⇓ anxiety & inhibitions
• Hypnosis: instigation of sleep
• Insomnia
– ⇑ Latent period
– ⇑ Wakenings
• Classes:
– Barbiturates
– Benzodiazepines
– Alcohol
• Sedation: ⇓ anxiety & inhibitions
• Hypnosis: instigation of sleep
• Insomnia
– ⇑ Latent period
– ⇑ Wakenings
• Classes:
– Barbiturates
– Benzodiazepines
– Alcohol
Chemically different,
Functionally similar
Chemically different,
Functionally similar
Mechanism of action
Mechanism of action
Mechanism of action
• Both promote the effectiveness of GABA
receptors in the CNS
– Benzodiazepines promote only
– Barbiturates promote and (at high doses)
stimulate GABA receptors
• GABA = chief CNS inhibitory
neurotransmitter
– Promotes hyperpolarization via ⇑ Cl- influx
• Both promote the effectiveness of GABA
receptors in the CNS
– Benzodiazepines promote only
– Barbiturates promote and (at high doses)
stimulate GABA receptors
• GABA = chief CNS inhibitory
neurotransmitter
– Promotes hyperpolarization via ⇑ Cl- influx
Benzodiazepines vs.
Barbiturates
Benzodiazepines vs.
Benzodiazepines vs.
Barbiturates
Barbiturates
Criteria BZ Barb.
Relative Safety High Low
Maximal CNS depression Low High
Respiratory Depression Low High
Suicide Potential Low High
Abuse Potential Low High
Antagonist Available? Yes No
Benzodiazepines
Benzodiazepines
Benzodiazepines
Benzodiazepines
• diazepam (Valium®)
• midazolam (Versed®)
• alprazolam (Xanax®)
• lorazepam (Atiavan®)
• triazolam (Halcion®)
Benzodiazepines
• diazepam (Valium®)
• midazolam (Versed®)
• alprazolam (Xanax®)
• lorazepam (Atiavan®)
• triazolam (Halcion®)
“Non-benzo benzo”
• zolpidem (Ambien®)
• buspirone (BusPar®)
“Non-benzo benzo”
• zolpidem (Ambien®)
• buspirone (BusPar®)
Barbiturates
Barbiturates
Barbiturates
Subgroup Prototype Typical
Indication
Ultra-short
acting
thiopental
(Pentothol®)
Anesthesia
Short acting secobarbital
(Seconal®)
Insomnia
Long acting phenobarbital
(Luminal®)
Seizures
Barbiturates
Barbiturates
Barbiturates
• amobarbital (Amytal®)
• pentobarbital (Nembutal®)
• thiopental (Pentothal®)
• phenobarbital (Luminal ®)
• secobarbital (Seconal ®)
• amobarbital (Amytal®)
• pentobarbital (Nembutal®)
• thiopental (Pentothal®)
• phenobarbital (Luminal ®)
• secobarbital (Seconal ®)
Anti-seizure Medications
Anti
Anti-
-seizure Medications
seizure Medications
• Seizures caused by hyperactive brain areas
• Multiple chemical classes of drugs
– All have same approach
– Decrease propagation of action potentials
• ⇓ Na+, Ca++ influx (delay depolarization/prolong
repolarization)
• ⇑ Cl- influx (hyperpolarize membrane)
• Seizures caused by hyperactive brain areas
• Multiple chemical classes of drugs
– All have same approach
– Decrease propagation of action potentials
• ⇓ Na+, Ca++ influx (delay depolarization/prolong
repolarization)
• ⇑ Cl- influx (hyperpolarize membrane)
Anti-Seizure Medications
Anti
Anti-
-Seizure Medications
Seizure Medications
Benzodiazepines
• diazepam (Valium®)
• lorazepam (Ativan®)
Barbiturates
• phenobarbital
(Luminal®)
Benzodiazepines
• diazepam (Valium®)
• lorazepam (Ativan®)
Barbiturates
• phenobarbital
(Luminal®)
Ion Channel Inhibitors
• carbamazepine
(Tegretol®)
• phenytoin (Dilantin®)
Misc. Agents
• valproic acid
(Depakote®)
Ion Channel Inhibitors
• carbamazepine
(Tegretol®)
• phenytoin (Dilantin®)
Misc. Agents
• valproic acid
(Depakote®)
Ion Diffusion
Ion Diffusion
Ion Diffusion
• Key to neurophysiology
• Dependent upon:
– Concentration gradient
– Electrical gradient
• Modified by:
– ‘Gated ion channels’
• Key to neurophysiology
• Dependent upon:
– Concentration gradient
– Electrical gradient
• Modified by:
– ‘Gated ion channels’
Where Does Diffusion Take the
Ion?
Where Does Diffusion Take the
Where Does Diffusion Take the
Ion?
Ion?
Exterior
Interior
K+
5 mM
K+
5 mM
Cl-
Low
Cl-
Low
Cl-
High
Cl-
High
K+
150 mM
K+
150 mM
Na+
15 mM
Na+
15 mM
Na+
150 mM
Na+
150 mM
O
U
T
O
U
T
I
N
I
N
I
N
I
N
Action Potential Components
Action Potential Components
Action Potential Components
Mem
brane
Poten
tial
(mV)
-50
+30
Threshold
Potential
-70
0
Time (msec)
Threshold
Potential
Resting Membrane
Potential
Resting Membrane
Potential
Na+ equilibrium
Na+ equilibrium
Action
Potential
Action
Potential
Depolarization!
Depolarization!
Hyperpolarized
Hyperpolarized
Membrane Permeability
Membrane Permeability
Membrane Permeability
Mem
brane
Poten
tial
(mV)
-50
+30
Threshold
Potential
-70
0
Time (msec)
Threshold
Potential
Resting Membrane
Potential
Resting Membrane
Potential
N
a
+
I
n
f
l
u
x
K
+
E
f
f
l
u
x
Mem
brane
Poten
tial
(mV)
-50
+30
Threshold
Potential
-70
0
Time (msec)
Threshold
Potential
Resting Membrane
Potential
Resting Membrane
Potential
N
a
+
I
n
f
l
u
x
K
+
E
f
f
l
u
x
It gets
hyperpolarized!
It gets
hyperpolarized!
What Happens to the Membrane If Cl-
Rushes Into the Cell During Repolarization?
What Happens to the Membrane If Cl-
Rushes Into the Cell During Repolarization?
Mem
brane
Poten
tial
(mV)
-50
+30
-70
0
Time (msec)
It
decreases!
It
decreases!
What Happens to the Frequency of Action
Potentials If the Membrane Gets
Hyperpolarized?
What Happens to the Frequency of Action
Potentials If the Membrane Gets
Hyperpolarized?
Clinical Correlation
Clinical Correlation
• Remember that it is the rate of action potential propagation
that determines neurologic function.
– Determined by frequency of action potentials.
• Remember that it is the rate of action potential propagation
that determines neurologic function.
– Determined by frequency of action potentials.
What is a seizure?
What is a seizure?
What would be the
effect on the membrane
of ⇑ Cl- influx
during a seizure?
What would be the
effect on the membrane
of ⇑ Cl- influx
during a seizure?
Hyperpolarization &
⇓ seizure
activity!
Gamma Amino Butyric Acid
Receptors
Gamma Amino Butyric Acid
Gamma Amino Butyric Acid
Receptors
Receptors GABA
Receptor
GABA
Receptor
Exterior
Interior
Cl -
Cl -
Hyperpolarized!
Hyperpolarized!
GABA+Bz Complex
GABA+Bz
GABA+Bz Complex
Complex
Bz
Receptor
Bz
Receptor
GABA
Receptor
GABA
Receptor
Exterior
Interior
Cl -
Cl -
Profoundly
Hyperpolarized!
Profoundly
Hyperpolarized!
Are You Ready for a Big
Surprise?
Are You Ready for a Big
Are You Ready for a Big
Surprise?
Surprise?
Many CNS drugs act on GABA
Many CNS drugs act on GABA
receptors to effect the frequency
receptors to effect the frequency
and duration of action potentials!
and duration of action potentials!
SNS Stimulants
SNS Stimulants
SNS Stimulants
• Two general mechanisms:
– Increase excitatory neurotransmitter release
– Decrease inhibitory neurotransmitter release
• Two general mechanisms:
– Increase excitatory neurotransmitter release
– Decrease inhibitory neurotransmitter release
• Three classes:
• Amphetamines
• Methylphendidate
• Methylxanthines
• Three classes:
• Amphetamines
• Methylphendidate
• Methylxanthines
Amphetamines
Amphetamines
Amphetamines
amphetamine
methamphetamine
dextroamphetamine
(Dexedrine®)
amphetamine
methamphetamine
dextroamphetamine
(Dexedrine®)
Side Effects
•Tachycardia
•Hypertension
•Convulsion
•Insomnia
•Psychosis
Side Effects
•Tachycardia
•Hypertension
•Convulsion
•Insomnia
•Psychosis
Indications
•Diet suppression
•⇓ Fatigue
•⇑ Concentration
Indications
•Diet suppression
•⇓ Fatigue
•⇑ Concentration
MOA:
promote release of
norepinephrine,
dopamine
MOA:
promote release of
norepinephrine,
dopamine
Methylphenidate (Ritalin®)
Methylphenidate (Ritalin
Methylphenidate (Ritalin®
®
)
)
• Different structure than other stimulants
– Similar mechanism
– Similar side effects
• Indication: ADHD
– Increase ability to focus & concentrate
• Different structure than other stimulants
– Similar mechanism
– Similar side effects
• Indication: ADHD
– Increase ability to focus & concentrate
Methylxanthines
Methylxanthines
Methylxanthines
• Caffeine
• Theophylline (Theo-Dur®)
• Aminophylline
Mechanism of action
• Reversible blockade of adenosine receptors
• Caffeine
• Theophylline (Theo-Dur®)
• Aminophylline
Mechanism of action
• Reversible blockade of adenosine receptors
A patient is taking theophylline and
becomes tachycardic (SVT). You want to
give her adenosine. Is there an interaction
you should be aware of? How should you
alter your therapy?
A patient is taking theophylline and
A patient is taking theophylline and
becomes tachycardic (SVT). You want to
becomes tachycardic (SVT). You want to
give her adenosine. Is there an interaction
give her adenosine. Is there an interaction
you should be aware of? How should you
you should be aware of? How should you
alter your therapy?
alter your therapy?
Methylxanthines blocks
adenosine receptors. A
typical dose of adenosine
may not be sufficient to
achieve the desired
result.
Methylxanthines blocks
adenosine receptors. A
typical dose of adenosine
may not be sufficient to
achieve the desired
result.
Double the
dose!
Double the
dose!
News You Can Use…
News You Can Use
News You Can Use…
…
Source Amount of Caffeine
Coffee
•Brewed
•Instant
40 – 180 mg/cup
30 – 120 mg/cup
Decaffeinated Coffee 2 - 5 mg/cup
Tea 20 – 110 mg/cup
Coke 40 – 60 mg/12 oz
Psychotherapeutic
Medications
Psychotherapeutic
Psychotherapeutic
Medications
Medications
• Dysfunction related to neurotransmitter
imbalance.
– Norepinephrine.
– Dopamine.
– Seratonin.
• Goal is to regulate excitory/inhibitory
neurotransmitters.
• Dysfunction related to neurotransmitter
imbalance.
– Norepinephrine.
– Dopamine.
– Seratonin.
• Goal is to regulate excitory/inhibitory
neurotransmitters.
Monoamines
Anti-Psychotic Drugs
(Neuroleptics)
Anti
Anti-
-Psychotic Drugs
Psychotic Drugs
(Neuroleptics)
(Neuroleptics)
• Schizophrenia
– Loss of contact with reality & disorganized
thoughts
– Probable cause: increased dopamine release
– Tx. Aimed at decreasing dopamine activity
• Schizophrenia
– Loss of contact with reality & disorganized
thoughts
– Probable cause: increased dopamine release
– Tx. Aimed at decreasing dopamine activity
Two Chemical
Classes:
Two Chemical
Classes:
• Phenothiazines
• chlorpromazine (Thorazine ®)
• Butyrophenones
• haloperidol (Haldol®)
• Phenothiazines
• chlorpromazine (Thorazine ®)
• Butyrophenones
• haloperidol (Haldol®)
Other Uses for Antipsychotics
Other Uses for
Other Uses for Antipsychotics
Antipsychotics
• Bipolar depression
• Tourette’s Syndrome
• Prevention of emesis
• Dementia (OBS)
• Temporary psychoses from other illness
• Bipolar depression
• Tourette’s Syndrome
• Prevention of emesis
• Dementia (OBS)
• Temporary psychoses from other illness
Antipsychotic MOA
Antipsychotic MOA
Antipsychotic MOA
• Mechanism is similar
• Strength ([]) vs. Potency (‘oomph’)
– Phenothiazines – low potency
– Butyrophenones – high potency
• Receptor Antagonism
– Dopamine2 in brain
– Muscarinic cholinergic
– Histamine
– Norepi at alpha1
• Mechanism is similar
• Strength ([]) vs. Potency (‘oomph’)
– Phenothiazines – low potency
– Butyrophenones – high potency
• Receptor Antagonism
– Dopamine2 in brain
– Muscarinic cholinergic
– Histamine
– Norepi at alpha1
Therapeutic effects
Uninteded effects
Antipsychotic Side Effects
Antipsychotic Side Effects
Antipsychotic Side Effects
• Generally short term
• Extrapyramidal symptoms (EPS)
• Anticholinergic effects (atropine-like)
– Dry mouth, blurred vision, photophobia, tachycardia,
constipation)
• Orthostatic hypotension
• Sedation
• Decreased seizure threshold
• Sexual dysfunction
• Generally short term
• Extrapyramidal symptoms (EPS)
• Anticholinergic effects (atropine-like)
– Dry mouth, blurred vision, photophobia, tachycardia,
constipation)
• Orthostatic hypotension
• Sedation
• Decreased seizure threshold
• Sexual dysfunction
Extrapyramidal Symptoms
Extrapyramidal Symptoms
Extrapyramidal Symptoms
Reaction Onset Features
Acute dystonia Hours to 5 days Spasm of tongue, neck, face &
back
Parkinsonism 5 – 30 days Tremor, shuffling gait, drooling,
stooped posture, instability
Akathesia 5 – 60 days Compulsive, repetitive motions;
agitation
Tarditive
dyskinesia
Months to years Lip-smacking, worm-like tongue
movement, ‘fly-catching’
Treatment of EPS
Treatment of EPS
Treatment of EPS
• Likely caused by blocking central
dopamine2 receptors responsible for
movement
• Anticholinergic therapy rapidly effective
– diphenhydramine (Benadryl®)
• Likely caused by blocking central
dopamine2 receptors responsible for
movement
• Anticholinergic therapy rapidly effective
– diphenhydramine (Benadryl®)
Antipsychotic Agents
Antipsychotic Agents
Antipsychotic Agents
• chlorpromazine (Thorazine®)
• thioridazine (Mellaril®)
• trifluoperazine (Stelazine®)
• haloperidol (Haldol®)
• chlorpromazine (Thorazine®)
• thioridazine (Mellaril®)
• trifluoperazine (Stelazine®)
• haloperidol (Haldol®)
Antidepressants
Antidepressants
Antidepressants
• Likely cause: inadequate monoamine levels
• Treatment options:
– Increasing NT synthesis in presynaptic end
bulb
– Increasing NT release from end bulb
– Blocking NT ‘reuptake’ by presynaptic end
bulb
• Likely cause: inadequate monoamine levels
• Treatment options:
– Increasing NT synthesis in presynaptic end
bulb
– Increasing NT release from end bulb
– Blocking NT ‘reuptake’ by presynaptic end
bulb
Tricyclic Antidepressants
(TCAs)
Tricyclic
Tricyclic Antidepressants
Antidepressants
(TCAs)
(TCAs)
• Block reuptake of both NE & serotonin
– Enhance effects
• Similar side effects to phenothiazines
• Block reuptake of both NE & serotonin
– Enhance effects
• Similar side effects to phenothiazines
TCA Side Effects
TCA Side Effects
TCA Side Effects
• Orthostatic hypotension
• Sedation
• Anticholinergic effects
• Cardiac toxicity
– Ventricular dysrythmias
• Orthostatic hypotension
• Sedation
• Anticholinergic effects
• Cardiac toxicity
– Ventricular dysrythmias
Selective Serotonin Reuptake
Inhibitors (SSRIs)
Selective Serotonin Reuptake
Selective Serotonin Reuptake
Inhibitors (SSRIs)
Inhibitors (SSRIs)
• Block only serotonin (not NE) reuptake
– Elevate serotonin levels
• Fewer side effects than TCS
– No hypotension
– No anticholinergic effects
– No cardiotoxicity
• Most common side effect
– Nausea, insomnia, sexual dysfunction
• Block only serotonin (not NE) reuptake
– Elevate serotonin levels
• Fewer side effects than TCS
– No hypotension
– No anticholinergic effects
– No cardiotoxicity
• Most common side effect
– Nausea, insomnia, sexual dysfunction
Monoamine Oxidase Inhibitors
(MAOIs)
Monoamine
Monoamine Oxidase
Oxidase Inhibitors
Inhibitors
(
(MAOIs
MAOIs)
)
• Monoamine oxidase
– Present in liver, intestines & MA releasing
neurons
– Inactivates monoamines
– Inactivates dietary tyramine in liver
• Foods rich in tyramine: cheese & red wine
• Monoamine oxidase
– Present in liver, intestines & MA releasing
neurons
– Inactivates monoamines
– Inactivates dietary tyramine in liver
• Foods rich in tyramine: cheese & red wine
MAOI Side Effects
MAOI Side Effects
MAOI Side Effects
• CNS Stimulation
– Anxiety, agitation
• Orthostatic hypotension
• Hypertensive Crisis
– From increased tyramine consumption
• Excessive arteriole constriction, stimulation of heart
• CNS Stimulation
– Anxiety, agitation
• Orthostatic hypotension
• Hypertensive Crisis
– From increased tyramine consumption
• Excessive arteriole constriction, stimulation of heart
MAOI & Dietary Tyramine
MAOI & Dietary Tyramine
MAOI & Dietary Tyramine
Antidepressant Mechanism
Antidepressant Mechanism
Antidepressant Mechanism
TCAs &
SSRIs
Block Here
Antidepressants Agents
Antidepressants Agents
Antidepressants Agents
TCAs
• imiprimine (Tofranil®)
• amitriptyline (Elavil®)
• nortriptyline (Pamelor ®)
SSRIs
• fluoxetine (Prozac®)
• paroxetine (Paxil®)
• sertraline (Zoloft®)
TCAs
• imiprimine (Tofranil®)
• amitriptyline (Elavil®)
• nortriptyline (Pamelor ®)
SSRIs
• fluoxetine (Prozac®)
• paroxetine (Paxil®)
• sertraline (Zoloft®)
MAOIs
• phenelzine (Nardil®)
Atypical Antidepressants
• bupropion (Wellbutrin®)
MAOIs
• phenelzine (Nardil®)
Atypical Antidepressants
• bupropion (Wellbutrin®)
Parkinson’s Disease
Parkinson
Parkinson’
’s Disease
s Disease
• Fine motor control dependent upon balance
between excitatory and inhibitory NT
– Acetylcholine = excitatory
– Dopamine =inhibitory
GABA= inhibitory
• Fine motor control dependent upon balance
between excitatory and inhibitory NT
– Acetylcholine = excitatory
– Dopamine =inhibitory
GABA= inhibitory
Control GABA
release
Parkinson’s Disease
Parkinson
Parkinson’
’s Disease
s Disease
Parkinson’s Symptoms:
Parkinson
Parkinson’
’s Symptoms:
s Symptoms:
• Similar to EPS
• Dyskinesias
– Tremors, unsteady gait, instability
• Bradykinesia
• Akinesia in severe cases
• Similar to EPS
• Dyskinesias
– Tremors, unsteady gait, instability
• Bradykinesia
• Akinesia in severe cases
Parkinson’s Treatment
Parkinson
Parkinson’
’s Treatment
s Treatment
• Dopaminergic approach
– ⇑ Release of dopamine
– ⇑ [Dopamine]
– ⇓ Dopamine breakdown
• Cholinergic approach
– ⇓ Amount of ACh released
– Directly block ACh receptors
• All treatment is symptomatic and temporary
• Dopaminergic approach
– ⇑ Release of dopamine
– ⇑ [Dopamine]
– ⇓ Dopamine breakdown
• Cholinergic approach
– ⇓ Amount of ACh released
– Directly block ACh receptors
• All treatment is symptomatic and temporary
Levodopa
Levodopa
Levodopa
• Sinemet ® = levodopa + carbidopa
• Increase central dopamine levels
• Side effects:
– Nausea and vomiting
– Dyskinesia (~80% of population)
– Cardiovascular (dysrythmias)
• Sinemet ® = levodopa + carbidopa
• Increase central dopamine levels
• Side effects:
– Nausea and vomiting
– Dyskinesia (~80% of population)
– Cardiovascular (dysrythmias)
Levodopa Mechanism
Levodopa
Levodopa Mechanism
Mechanism
Other Agents
Other Agents
Other Agents
• amantadine (Symmetrel®)
– ⇑ release of dopamine from unaffected neurons
• bromocriptine (Parlodel®)
– Directly stimulated dopamine receptors
• selegiline (Carbex®, Eldepryl®)
– MAOI selective for dopamine (MAO-B)
• benztropine (Cogentin®)
– Centrally acting anticholinergic
• amantadine (Symmetrel®)
– ⇑ release of dopamine from unaffected neurons
• bromocriptine (Parlodel®)
– Directly stimulated dopamine receptors
• selegiline (Carbex®, Eldepryl®)
– MAOI selective for dopamine (MAO-B)
• benztropine (Cogentin®)
– Centrally acting anticholinergic
Drugs That Affect the
Autonomic Nervous System
Drugs That Affect the
Drugs That Affect the
Autonomic Nervous System
Autonomic Nervous System
Word of Warning
Carefully review the A&P material &
tables on pages 309 – 314 and 317 – 321!
Word of Warning
Carefully review the A&P material &
tables on pages 309 – 314 and 317 – 321!
PNS Drugs
PNS Drugs
PNS Drugs
• Cholinergic
– Agonists & Antagonistis (Anticholinergics)
– Based on response at nicotinic(N&M) &
muscarinic receptors
• Cholinergic
– Agonists & Antagonistis (Anticholinergics)
– Based on response at nicotinic(N&M) &
muscarinic receptors
Acetylcholine Receptors
Acetylcholine Receptors
Acetylcholine Receptors
Figure 9-8, page 313, Paramedic Care, V1
Cholinergic Agonists
Cholinergic Agonists
Cholinergic Agonists
Salivation
Lacrimation
Urination
Defecation
Gastric motility
Emesis
Salivation
Lacrimation
Urination
Defecation
Gastric motility
Emesis
Cholinergic agents
cause SLUDGE!
HINT!
These effects are
predictable by knowing
PNS physiology (table 9-4)
Direct Acting Cholinergics
Direct Acting
Direct Acting Cholinergics
Cholinergics
• bethanechol (Urecholine) prototype
– Direct stimulation of ACh receptors
– Used for urinary hesitancy and constipation
• bethanechol (Urecholine) prototype
– Direct stimulation of ACh receptors
– Used for urinary hesitancy and constipation
Indirect Acting Cholinergics
Indirect Acting
Indirect Acting Cholinergics
Cholinergics
• Inhibit ChE (cholinesterase) to prolong the
duration of ACh stimulation in synapse
• Reversible
• Irreversible
• Inhibit ChE (cholinesterase) to prolong the
duration of ACh stimulation in synapse
• Reversible
• Irreversible
Reversible ChE Inhibitors
Reversible ChE Inhibitors
Reversible ChE Inhibitors
• neostigmine (Prostigmine®)
– Myasthenia Gravis at nicotinicM receptors
– Can reverse nondepolarizing neuromuscular
blockade
• physostigmine (Antilirium®)
– Shorter onset of action
– Used for iatrogenic atropine overdoses @
muscarinic receptors
• neostigmine (Prostigmine®)
– Myasthenia Gravis at nicotinicM receptors
– Can reverse nondepolarizing neuromuscular
blockade
• physostigmine (Antilirium®)
– Shorter onset of action
– Used for iatrogenic atropine overdoses @
muscarinic receptors
Irreversible ChE Inhibitors
Irreversible ChE Inhibitors
Irreversible ChE Inhibitors
• Very rarely used clinically
• Very common in insecticides & chemical
weapons
– VX and Sarin gas
– Cause SLUDGE dammit and paralysis
• Tx: atropine and pralidoxime (2-PAM®)
– Anticholinergics
• Very rarely used clinically
• Very common in insecticides & chemical
weapons
– VX and Sarin gas
– Cause SLUDGE dammit and paralysis
• Tx: atropine and pralidoxime (2-PAM®)
– Anticholinergics
Anticholinergics
Anticholinergics
Anticholinergics
• Muscarinic
antagonists
– Atropine
• Ganglionic antagonists
– block nicotinicN
receptors
– Turns off the ANS!
– trimethaphan
(Arfonad®)
• Hypertensive crisis
• Muscarinic
antagonists
– Atropine
• Ganglionic antagonists
– block nicotinicN
receptors
– Turns off the ANS!
– trimethaphan
(Arfonad®)
• Hypertensive crisis
• Atropine Overdose
– Dry mouth, blurred
vision, anhidrosis
• Atropine Overdose
– Dry mouth, blurred
vision, anhidrosis
Hot as Hell
Blind as a Bat
Dry as a Bone
Red as a Beet
Mad as a Hatter
Hot as Hell
Blind as a Bat
Dry as a Bone
Red as a Beet
Mad as a Hatter
Neuromuscular Blockers
Neuromuscular Blockers
Neuromuscular Blockers
• Nicotinic Cholinergic Antagonists
– Given to induce paralysis
• Depolarizing
– succinylcholine (Anectin®)
• Nondepolarizing
– tubocurarine from curare
– rocuronium (Zemuron®)
– vecuronium (Norcuron®)
• Nicotinic Cholinergic Antagonists
– Given to induce paralysis
• Depolarizing
– succinylcholine (Anectin®)
• Nondepolarizing
– tubocurarine from curare
– rocuronium (Zemuron®)
– vecuronium (Norcuron®)
Warning!
Warning!
Warning!
• Paralysis without loss of consciousness!
– MUST also give sedative-hypnotic
– Common agents:
• fentanyl (Sublimaze®)
• midazolam (Versed®)
• Paralysis without loss of consciousness!
– MUST also give sedative-hypnotic
– Common agents:
• fentanyl (Sublimaze®)
• midazolam (Versed®)
SNS Drugs
SNS Drugs
SNS Drugs
• Predictable response based on knowledge of
affects of adrenergic receptor stimulation
• HINT: Know table 9-5, page 321
• Each receptor may be:
– Stimulated (sympathomimetic)
– Inhibitied (sympatholytic)
• Predictable response based on knowledge of
affects of adrenergic receptor stimulation
• HINT: Know table 9-5, page 321
• Each receptor may be:
– Stimulated (sympathomimetic)
– Inhibitied (sympatholytic)
Alpha1 Agonists
Alpha
Alpha1
1 Agonists
Agonists
• Profound vasoconstriction
– Increases afterload & blood pressure when
given systemically
– Decreases drug absorption & bleeding when
given topically
• Profound vasoconstriction
– Increases afterload & blood pressure when
given systemically
– Decreases drug absorption & bleeding when
given topically
Alpha1 Antagonism
Alpha
Alpha1
1 Antagonism
Antagonism
• Inhibits peripheral vasoconstriction
– Used for hypertension
– prazosin (Minipress®)
– doxazosin (Cardura®)
– phentolamine (Regitine®)
• Blocks alpha1&2 receptors
• Inhibits peripheral vasoconstriction
– Used for hypertension
– prazosin (Minipress®)
– doxazosin (Cardura®)
– phentolamine (Regitine®)
• Blocks alpha1&2 receptors
Beta1 Agonists
Beta
Beta1
1 Agonists
Agonists
• Increases heart rate, contractility, and
conductivity
• Increases heart rate, contractility, and
conductivity
Beta Antagonists (β Blockers)
Beta Antagonists (
Beta Antagonists (β
β Blockers)
Blockers)
• Frequently used
• Lower Blood Pressure
• Negative chronotropes & inotropes
• Frequently used
• Lower Blood Pressure
• Negative chronotropes & inotropes
Beta1 Selective Blockade
• atenolol (Tenormin®)
• esmolol (Brevibloc®)
• metoprolol (Lopressor®)
Beta1 Selective Blockade
• atenolol (Tenormin®)
• esmolol (Brevibloc®)
• metoprolol (Lopressor®)
Nonselective
• propranolol (Inderal®)
• labetalol (Normodyne®,
Trandate®)
• sotalol (Betapace®)
Nonselective
• propranolol (Inderal®)
• labetalol (Normodyne®,
Trandate®)
• sotalol (Betapace®)
Adrenergic Receptor Specificity
Adrenergic Receptor Specificity
Adrenergic Receptor Specificity
Drug α1 α2 β1 β2 Dopaminergic
Epinephrine
Ephedrine
Norepinephrine
Phenylephrine
Isoproterenol
Dopamine
Dobutamine
terbutaline
Web Resources
Web Resources
Web Resources
• Web based synaptic transmission project
– http://www.williams.edu/imput/index.html
• Web based synaptic transmission project
– http://www.williams.edu/imput/index.html
Thank You!
Thank You!
Thank You!
• To Temple College EMS Professions for
permission to use their materials
• To Temple College EMS Professions for
permission to use their materials

More Related Content

Similar to cns-drugs.pdf

Cholinergic drugs.pptx
Cholinergic drugs.pptxCholinergic drugs.pptx
Cholinergic drugs.pptx
AliReza844553
 
Anti seizure and rescue medications.updated 8.7.2014
Anti seizure and rescue medications.updated 8.7.2014Anti seizure and rescue medications.updated 8.7.2014
Anti seizure and rescue medications.updated 8.7.2014
Cleveland Clinic
 
Drugs-Acting-on-CNS.pptx
Drugs-Acting-on-CNS.pptxDrugs-Acting-on-CNS.pptx
Drugs-Acting-on-CNS.pptx
NARESHJANDIAL1
 
Adrenergic receptor and mechanism of action by yehia matter
Adrenergic receptor and mechanism of action by yehia matter Adrenergic receptor and mechanism of action by yehia matter
Adrenergic receptor and mechanism of action by yehia matter
yehiamatter
 
Drug used in nervous system final auto saved
Drug used in nervous system final auto savedDrug used in nervous system final auto saved
Drug used in nervous system final auto saved
balajiphotostat
 
Analgesic & antipyretic drugs
Analgesic & antipyretic drugsAnalgesic & antipyretic drugs
Analgesic & antipyretic drugs
ZannatunnesaBristi
 
Antianxiety
AntianxietyAntianxiety
Antianxiety
madhavsiree
 
Dru gsodium vaoprate converted
Dru gsodium  vaoprate convertedDru gsodium  vaoprate converted
Dru gsodium vaoprate converted
RAMA COLLAGE OF NURSING
 
Pharm ans
Pharm ansPharm ans
Pharm ans
Jamshiya Manshad
 
Pharmacology by category
Pharmacology by categoryPharmacology by category
Pharmacology by category
shayiamk
 
ANTI CHOLINERGIC DRUGS
ANTI CHOLINERGIC DRUGSANTI CHOLINERGIC DRUGS
ANTI CHOLINERGIC DRUGS
Dr. JITENDER BANSI
 
Pharmacotherapy of depression
Pharmacotherapy of depressionPharmacotherapy of depression
Pharmacotherapy of depression
Dr.Ameya Puranik
 
Central Nervous System Agents
Central Nervous System AgentsCentral Nervous System Agents
Central Nervous System Agents
Tosca Torres
 
HYPNOTIC & SEDATIVES for class.pptx
HYPNOTIC & SEDATIVES for class.pptxHYPNOTIC & SEDATIVES for class.pptx
HYPNOTIC & SEDATIVES for class.pptx
ssuser67b275
 
Autonomic system and Autonomic Pharmacology
Autonomic system and Autonomic PharmacologyAutonomic system and Autonomic Pharmacology
Autonomic system and Autonomic Pharmacology
Reza Heidari
 
Drugs used in nervous system
Drugs used in nervous systemDrugs used in nervous system
Drugs used in nervous system
Abhay Rajpoot
 
Psychobiology and psychotropic drugs order 4
Psychobiology and psychotropic drugs   order 4Psychobiology and psychotropic drugs   order 4
Psychobiology and psychotropic drugs order 4
rfranquiz1
 
99994138.ppt
99994138.ppt99994138.ppt
99994138.ppt
ssuser497f37
 
Cholinergic pharmacology younus h johan 2016
Cholinergic pharmacology younus h johan 2016Cholinergic pharmacology younus h johan 2016
Cholinergic pharmacology younus h johan 2016
younus johan
 
Antipsychotics LAST MINUTE REVISION NOTES
Antipsychotics LAST MINUTE REVISION NOTESAntipsychotics LAST MINUTE REVISION NOTES
Antipsychotics LAST MINUTE REVISION NOTES
TONY SCARIA
 

Similar to cns-drugs.pdf (20)

Cholinergic drugs.pptx
Cholinergic drugs.pptxCholinergic drugs.pptx
Cholinergic drugs.pptx
 
Anti seizure and rescue medications.updated 8.7.2014
Anti seizure and rescue medications.updated 8.7.2014Anti seizure and rescue medications.updated 8.7.2014
Anti seizure and rescue medications.updated 8.7.2014
 
Drugs-Acting-on-CNS.pptx
Drugs-Acting-on-CNS.pptxDrugs-Acting-on-CNS.pptx
Drugs-Acting-on-CNS.pptx
 
Adrenergic receptor and mechanism of action by yehia matter
Adrenergic receptor and mechanism of action by yehia matter Adrenergic receptor and mechanism of action by yehia matter
Adrenergic receptor and mechanism of action by yehia matter
 
Drug used in nervous system final auto saved
Drug used in nervous system final auto savedDrug used in nervous system final auto saved
Drug used in nervous system final auto saved
 
Analgesic & antipyretic drugs
Analgesic & antipyretic drugsAnalgesic & antipyretic drugs
Analgesic & antipyretic drugs
 
Antianxiety
AntianxietyAntianxiety
Antianxiety
 
Dru gsodium vaoprate converted
Dru gsodium  vaoprate convertedDru gsodium  vaoprate converted
Dru gsodium vaoprate converted
 
Pharm ans
Pharm ansPharm ans
Pharm ans
 
Pharmacology by category
Pharmacology by categoryPharmacology by category
Pharmacology by category
 
ANTI CHOLINERGIC DRUGS
ANTI CHOLINERGIC DRUGSANTI CHOLINERGIC DRUGS
ANTI CHOLINERGIC DRUGS
 
Pharmacotherapy of depression
Pharmacotherapy of depressionPharmacotherapy of depression
Pharmacotherapy of depression
 
Central Nervous System Agents
Central Nervous System AgentsCentral Nervous System Agents
Central Nervous System Agents
 
HYPNOTIC & SEDATIVES for class.pptx
HYPNOTIC & SEDATIVES for class.pptxHYPNOTIC & SEDATIVES for class.pptx
HYPNOTIC & SEDATIVES for class.pptx
 
Autonomic system and Autonomic Pharmacology
Autonomic system and Autonomic PharmacologyAutonomic system and Autonomic Pharmacology
Autonomic system and Autonomic Pharmacology
 
Drugs used in nervous system
Drugs used in nervous systemDrugs used in nervous system
Drugs used in nervous system
 
Psychobiology and psychotropic drugs order 4
Psychobiology and psychotropic drugs   order 4Psychobiology and psychotropic drugs   order 4
Psychobiology and psychotropic drugs order 4
 
99994138.ppt
99994138.ppt99994138.ppt
99994138.ppt
 
Cholinergic pharmacology younus h johan 2016
Cholinergic pharmacology younus h johan 2016Cholinergic pharmacology younus h johan 2016
Cholinergic pharmacology younus h johan 2016
 
Antipsychotics LAST MINUTE REVISION NOTES
Antipsychotics LAST MINUTE REVISION NOTESAntipsychotics LAST MINUTE REVISION NOTES
Antipsychotics LAST MINUTE REVISION NOTES
 

Recently uploaded

Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Ayurveda ForAll
 
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
chandankumarsmartiso
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
The Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in IndiaThe Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in India
Swastik Ayurveda
 
Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptxIdentification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptx
MGM SCHOOL/COLLEGE OF NURSING
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
Dr. Jyothirmai Paindla
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
KafrELShiekh University
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 

Recently uploaded (20)

Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
 
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
 
The Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in IndiaThe Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in India
 
Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptxIdentification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptx
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 

cns-drugs.pdf

  • 1. Pharmacology Pharmacology Pharmacology Drugs That Affect The: Nervous System Drugs That Affect The: Nervous System
  • 2. Topics Topics Topics • Analgesics and antagonists • Anesthetics • Anti-anxiety and sedative-hypnotics • Anti-seizure / anti-convulsants • CNS stimulators • Psychotherapeutics • ANS/PNS/SNS agents • Analgesics and antagonists • Anesthetics • Anti-anxiety and sedative-hypnotics • Anti-seizure / anti-convulsants • CNS stimulators • Psychotherapeutics • ANS/PNS/SNS agents
  • 3. A colorful review of neurophysiology! A colorful review of neurophysiology! But first... But first... But first...
  • 4. Nervous System Nervous System Nervous System CNS CNS PNS PNS Somatic Somatic Autonomic Autonomic Parasympathetic Parasympathetic Sympathetic Sympathetic
  • 5. Analgesics Analgesics Analgesics • Decrease in sensation of pain. • Classes: – Opioid. • Agonist. • Antagonist. • Agonist-antagonist. – Non-opioids. • Salicylates. • NSAIDs. • Adjuncts. • Decrease in sensation of pain. • Classes: – Opioid. • Agonist. • Antagonist. • Agonist-antagonist. – Non-opioids. • Salicylates. • NSAIDs. • Adjuncts.
  • 6. Opioids Opioids Opioids • Generic reference to morphine-like drugs/actions – Opiate: derivative of opium • Prototype: morphine – Morpheus: god of dreams • Act on endorphin receptors: – Mu (most important) – Kappa • Generic reference to morphine-like drugs/actions – Opiate: derivative of opium • Prototype: morphine – Morpheus: god of dreams • Act on endorphin receptors: – Mu (most important) – Kappa
  • 7. Actions of Opioid Receptors Actions of Opioid Receptors Actions of Opioid Receptors Response Mu Kappa Analgesia ; ; Respiratory Depression ; Sedation ; ; Euphoria ; Physical Dependence ; ⇓ GI motility ; ;
  • 8. Actions at Opioid Receptors Actions at Opioid Receptors Actions at Opioid Receptors Drugs Mu Kappa Pure Agonists -morphine, codeine, meperidine (Demerol®), fentanyl (Sublimaze®), remifentanil (Ultiva®), propoxyphene (Darvon®), hydrocodone (Vicodin®), oxycodone (Percocet®) Agonist Agonist Agonist-Antagonist -nalbuphine (Nubaine®), butorphanol (Stadol®) Antagonist Agonist Pure Antagonist -naloxone (Narcan®) Antagonist Antagonist
  • 9. General Actions of Opioids General Actions of Opioids General Actions of Opioids • Analgesia • Respiratory depression • Constipation • Urinary retention • Cough suppression • Emesis • Increased ICP – Indirect through CO2 retention • Analgesia • Respiratory depression • Constipation • Urinary retention • Cough suppression • Emesis • Increased ICP – Indirect through CO2 retention • Euphoria/Dysphoria • Sedation • Miosis – Pupil constriction • ⇓ Preload & afterload – Watch for hypotension! • Euphoria/Dysphoria • Sedation • Miosis – Pupil constriction • ⇓ Preload & afterload – Watch for hypotension!
  • 10. Non-opioid Analgesics Non Non- -opioid opioid Analgesics Analgesics • Salicylates – Aspirin (Bayer® ) * (prototype for class) • Non-Steroidal Anti-Inflammatory Drugs • Ibuprofen (Motrin®, Advil®) – Propionic Acid derivative • Naproxen (Naprosyn®) • Naproxen sodium (Aleve®) • All compete with aspirin for protein binding sites – Ketorolac (Toradol®) • Salicylates – Aspirin (Bayer® ) * (prototype for class) • Non-Steroidal Anti-Inflammatory Drugs • Ibuprofen (Motrin®, Advil®) – Propionic Acid derivative • Naproxen (Naprosyn®) • Naproxen sodium (Aleve®) • All compete with aspirin for protein binding sites – Ketorolac (Toradol®)
  • 11. NSAID Properties NSAID Properties NSAID Properties Drug Fever Inflammation Pain Aspirin ; ; ; Ibuprofen ; ; ; Acetaminophen ; ;
  • 12. Aspirin Mechanism of Action Aspirin Mechanism of Action Aspirin Mechanism of Action • Inhibit synthesis of cyclooxygenase (COX) – Enzyme responsible for synthesis of: • Inhibit synthesis of cyclooxygenase (COX) – Enzyme responsible for synthesis of: Prostaglandins –Pain response –Suppression of gastric acid secretion –Promote secretion of gastric mucus and bicarbonate –Mediation of inflammatory response –Production of fever –Promote renal vasodilation (⇑ blood flow) –Promote uterine contraction Prostaglandins –Pain response –Suppression of gastric acid secretion –Promote secretion of gastric mucus and bicarbonate –Mediation of inflammatory response –Production of fever –Promote renal vasodilation (⇑ blood flow) –Promote uterine contraction Thromboxane A2 –Involved in platelet –aggregation Thromboxane A2 –Involved in platelet –aggregation
  • 13. Aspirin Effects Aspirin Effects Aspirin Effects Good • Pain relief • ⇓ Fever • ⇓ Inflammation Good • Pain relief • ⇓ Fever • ⇓ Inflammation Bad • GI ulceration: – ⇑ Gastric acidity – ⇓ GI protection • ⇑ Bleeding • ⇓ Renal elimination • ⇓ Uterine contractions during labor Bad • GI ulceration: – ⇑ Gastric acidity – ⇓ GI protection • ⇑ Bleeding • ⇓ Renal elimination • ⇓ Uterine contractions during labor
  • 14. Acetaminophen (Tylenol®) Acetaminophen (Tylenol Acetaminophen (Tylenol® ® ) ) • NSAID similar to aspirin • Only inhibits synthesis of CNS prostaglandins – Does not have peripheral side effects of ASA: • Gastric ulceration • ⇓ Platelet aggregation • ⇓ Renal flow • ⇓ Uterine contractions • NSAID similar to aspirin • Only inhibits synthesis of CNS prostaglandins – Does not have peripheral side effects of ASA: • Gastric ulceration • ⇓ Platelet aggregation • ⇓ Renal flow • ⇓ Uterine contractions
  • 15. Acetaminophen Metabolism Acetaminophen Metabolism Acetaminophen Metabolism Acetaminophen Acetaminophen Non-toxic metabolites Non-toxic metabolites Major Pathway Minor Pathway P-450 Toxic metabolites Toxic metabolites Non-toxic metabolites Non-toxic metabolites Induced by ETOH Induced by ETOH Glutathione Depleted by ETOH & APAP overdose Depleted by ETOH & APAP overdose
  • 16. Anesthetics Anesthetics Anesthetics • Loss of all sensation – Usually with loss of consciousness – ⇓ propagation of neural impulses • General anesthetics – Gases • Nitrous oxide (Nitronox®), halothane, ether – IV • Thiopental (Pentothal®), methohexital (Brevitol®), diazepam (valium®), remifentanil (Ultiva®) • Loss of all sensation – Usually with loss of consciousness – ⇓ propagation of neural impulses • General anesthetics – Gases • Nitrous oxide (Nitronox®), halothane, ether – IV • Thiopental (Pentothal®), methohexital (Brevitol®), diazepam (valium®), remifentanil (Ultiva®)
  • 17. Anesthetics Anesthetics Anesthetics • Local – Affect on area around injection – Usually accompanied by epinephrine • Lidocaine (Xylocaine ®), topical cocaine • Local – Affect on area around injection – Usually accompanied by epinephrine • Lidocaine (Xylocaine ®), topical cocaine
  • 18. Anti-anxiety & Sedative- hypnotic Drugs Anti Anti- -anxiety & Sedative anxiety & Sedative- - hypnotic Drugs hypnotic Drugs • Sedation: ⇓ anxiety & inhibitions • Hypnosis: instigation of sleep • Insomnia – ⇑ Latent period – ⇑ Wakenings • Classes: – Barbiturates – Benzodiazepines – Alcohol • Sedation: ⇓ anxiety & inhibitions • Hypnosis: instigation of sleep • Insomnia – ⇑ Latent period – ⇑ Wakenings • Classes: – Barbiturates – Benzodiazepines – Alcohol Chemically different, Functionally similar Chemically different, Functionally similar
  • 19. Mechanism of action Mechanism of action Mechanism of action • Both promote the effectiveness of GABA receptors in the CNS – Benzodiazepines promote only – Barbiturates promote and (at high doses) stimulate GABA receptors • GABA = chief CNS inhibitory neurotransmitter – Promotes hyperpolarization via ⇑ Cl- influx • Both promote the effectiveness of GABA receptors in the CNS – Benzodiazepines promote only – Barbiturates promote and (at high doses) stimulate GABA receptors • GABA = chief CNS inhibitory neurotransmitter – Promotes hyperpolarization via ⇑ Cl- influx
  • 20. Benzodiazepines vs. Barbiturates Benzodiazepines vs. Benzodiazepines vs. Barbiturates Barbiturates Criteria BZ Barb. Relative Safety High Low Maximal CNS depression Low High Respiratory Depression Low High Suicide Potential Low High Abuse Potential Low High Antagonist Available? Yes No
  • 21. Benzodiazepines Benzodiazepines Benzodiazepines Benzodiazepines • diazepam (Valium®) • midazolam (Versed®) • alprazolam (Xanax®) • lorazepam (Atiavan®) • triazolam (Halcion®) Benzodiazepines • diazepam (Valium®) • midazolam (Versed®) • alprazolam (Xanax®) • lorazepam (Atiavan®) • triazolam (Halcion®) “Non-benzo benzo” • zolpidem (Ambien®) • buspirone (BusPar®) “Non-benzo benzo” • zolpidem (Ambien®) • buspirone (BusPar®)
  • 22. Barbiturates Barbiturates Barbiturates Subgroup Prototype Typical Indication Ultra-short acting thiopental (Pentothol®) Anesthesia Short acting secobarbital (Seconal®) Insomnia Long acting phenobarbital (Luminal®) Seizures
  • 23. Barbiturates Barbiturates Barbiturates • amobarbital (Amytal®) • pentobarbital (Nembutal®) • thiopental (Pentothal®) • phenobarbital (Luminal ®) • secobarbital (Seconal ®) • amobarbital (Amytal®) • pentobarbital (Nembutal®) • thiopental (Pentothal®) • phenobarbital (Luminal ®) • secobarbital (Seconal ®)
  • 24. Anti-seizure Medications Anti Anti- -seizure Medications seizure Medications • Seizures caused by hyperactive brain areas • Multiple chemical classes of drugs – All have same approach – Decrease propagation of action potentials • ⇓ Na+, Ca++ influx (delay depolarization/prolong repolarization) • ⇑ Cl- influx (hyperpolarize membrane) • Seizures caused by hyperactive brain areas • Multiple chemical classes of drugs – All have same approach – Decrease propagation of action potentials • ⇓ Na+, Ca++ influx (delay depolarization/prolong repolarization) • ⇑ Cl- influx (hyperpolarize membrane)
  • 25. Anti-Seizure Medications Anti Anti- -Seizure Medications Seizure Medications Benzodiazepines • diazepam (Valium®) • lorazepam (Ativan®) Barbiturates • phenobarbital (Luminal®) Benzodiazepines • diazepam (Valium®) • lorazepam (Ativan®) Barbiturates • phenobarbital (Luminal®) Ion Channel Inhibitors • carbamazepine (Tegretol®) • phenytoin (Dilantin®) Misc. Agents • valproic acid (Depakote®) Ion Channel Inhibitors • carbamazepine (Tegretol®) • phenytoin (Dilantin®) Misc. Agents • valproic acid (Depakote®)
  • 26. Ion Diffusion Ion Diffusion Ion Diffusion • Key to neurophysiology • Dependent upon: – Concentration gradient – Electrical gradient • Modified by: – ‘Gated ion channels’ • Key to neurophysiology • Dependent upon: – Concentration gradient – Electrical gradient • Modified by: – ‘Gated ion channels’
  • 27. Where Does Diffusion Take the Ion? Where Does Diffusion Take the Where Does Diffusion Take the Ion? Ion? Exterior Interior K+ 5 mM K+ 5 mM Cl- Low Cl- Low Cl- High Cl- High K+ 150 mM K+ 150 mM Na+ 15 mM Na+ 15 mM Na+ 150 mM Na+ 150 mM O U T O U T I N I N I N I N
  • 28. Action Potential Components Action Potential Components Action Potential Components Mem brane Poten tial (mV) -50 +30 Threshold Potential -70 0 Time (msec) Threshold Potential Resting Membrane Potential Resting Membrane Potential Na+ equilibrium Na+ equilibrium Action Potential Action Potential Depolarization! Depolarization! Hyperpolarized Hyperpolarized
  • 29. Membrane Permeability Membrane Permeability Membrane Permeability Mem brane Poten tial (mV) -50 +30 Threshold Potential -70 0 Time (msec) Threshold Potential Resting Membrane Potential Resting Membrane Potential N a + I n f l u x K + E f f l u x
  • 30. Mem brane Poten tial (mV) -50 +30 Threshold Potential -70 0 Time (msec) Threshold Potential Resting Membrane Potential Resting Membrane Potential N a + I n f l u x K + E f f l u x It gets hyperpolarized! It gets hyperpolarized! What Happens to the Membrane If Cl- Rushes Into the Cell During Repolarization? What Happens to the Membrane If Cl- Rushes Into the Cell During Repolarization?
  • 31. Mem brane Poten tial (mV) -50 +30 -70 0 Time (msec) It decreases! It decreases! What Happens to the Frequency of Action Potentials If the Membrane Gets Hyperpolarized? What Happens to the Frequency of Action Potentials If the Membrane Gets Hyperpolarized?
  • 32. Clinical Correlation Clinical Correlation • Remember that it is the rate of action potential propagation that determines neurologic function. – Determined by frequency of action potentials. • Remember that it is the rate of action potential propagation that determines neurologic function. – Determined by frequency of action potentials. What is a seizure? What is a seizure? What would be the effect on the membrane of ⇑ Cl- influx during a seizure? What would be the effect on the membrane of ⇑ Cl- influx during a seizure? Hyperpolarization & ⇓ seizure activity!
  • 33. Gamma Amino Butyric Acid Receptors Gamma Amino Butyric Acid Gamma Amino Butyric Acid Receptors Receptors GABA Receptor GABA Receptor Exterior Interior Cl - Cl - Hyperpolarized! Hyperpolarized!
  • 35. Are You Ready for a Big Surprise? Are You Ready for a Big Are You Ready for a Big Surprise? Surprise? Many CNS drugs act on GABA Many CNS drugs act on GABA receptors to effect the frequency receptors to effect the frequency and duration of action potentials! and duration of action potentials!
  • 36. SNS Stimulants SNS Stimulants SNS Stimulants • Two general mechanisms: – Increase excitatory neurotransmitter release – Decrease inhibitory neurotransmitter release • Two general mechanisms: – Increase excitatory neurotransmitter release – Decrease inhibitory neurotransmitter release • Three classes: • Amphetamines • Methylphendidate • Methylxanthines • Three classes: • Amphetamines • Methylphendidate • Methylxanthines
  • 38. Methylphenidate (Ritalin®) Methylphenidate (Ritalin Methylphenidate (Ritalin® ® ) ) • Different structure than other stimulants – Similar mechanism – Similar side effects • Indication: ADHD – Increase ability to focus & concentrate • Different structure than other stimulants – Similar mechanism – Similar side effects • Indication: ADHD – Increase ability to focus & concentrate
  • 39. Methylxanthines Methylxanthines Methylxanthines • Caffeine • Theophylline (Theo-Dur®) • Aminophylline Mechanism of action • Reversible blockade of adenosine receptors • Caffeine • Theophylline (Theo-Dur®) • Aminophylline Mechanism of action • Reversible blockade of adenosine receptors
  • 40. A patient is taking theophylline and becomes tachycardic (SVT). You want to give her adenosine. Is there an interaction you should be aware of? How should you alter your therapy? A patient is taking theophylline and A patient is taking theophylline and becomes tachycardic (SVT). You want to becomes tachycardic (SVT). You want to give her adenosine. Is there an interaction give her adenosine. Is there an interaction you should be aware of? How should you you should be aware of? How should you alter your therapy? alter your therapy? Methylxanthines blocks adenosine receptors. A typical dose of adenosine may not be sufficient to achieve the desired result. Methylxanthines blocks adenosine receptors. A typical dose of adenosine may not be sufficient to achieve the desired result. Double the dose! Double the dose!
  • 41. News You Can Use… News You Can Use News You Can Use… … Source Amount of Caffeine Coffee •Brewed •Instant 40 – 180 mg/cup 30 – 120 mg/cup Decaffeinated Coffee 2 - 5 mg/cup Tea 20 – 110 mg/cup Coke 40 – 60 mg/12 oz
  • 42. Psychotherapeutic Medications Psychotherapeutic Psychotherapeutic Medications Medications • Dysfunction related to neurotransmitter imbalance. – Norepinephrine. – Dopamine. – Seratonin. • Goal is to regulate excitory/inhibitory neurotransmitters. • Dysfunction related to neurotransmitter imbalance. – Norepinephrine. – Dopamine. – Seratonin. • Goal is to regulate excitory/inhibitory neurotransmitters. Monoamines
  • 43. Anti-Psychotic Drugs (Neuroleptics) Anti Anti- -Psychotic Drugs Psychotic Drugs (Neuroleptics) (Neuroleptics) • Schizophrenia – Loss of contact with reality & disorganized thoughts – Probable cause: increased dopamine release – Tx. Aimed at decreasing dopamine activity • Schizophrenia – Loss of contact with reality & disorganized thoughts – Probable cause: increased dopamine release – Tx. Aimed at decreasing dopamine activity Two Chemical Classes: Two Chemical Classes: • Phenothiazines • chlorpromazine (Thorazine ®) • Butyrophenones • haloperidol (Haldol®) • Phenothiazines • chlorpromazine (Thorazine ®) • Butyrophenones • haloperidol (Haldol®)
  • 44. Other Uses for Antipsychotics Other Uses for Other Uses for Antipsychotics Antipsychotics • Bipolar depression • Tourette’s Syndrome • Prevention of emesis • Dementia (OBS) • Temporary psychoses from other illness • Bipolar depression • Tourette’s Syndrome • Prevention of emesis • Dementia (OBS) • Temporary psychoses from other illness
  • 45. Antipsychotic MOA Antipsychotic MOA Antipsychotic MOA • Mechanism is similar • Strength ([]) vs. Potency (‘oomph’) – Phenothiazines – low potency – Butyrophenones – high potency • Receptor Antagonism – Dopamine2 in brain – Muscarinic cholinergic – Histamine – Norepi at alpha1 • Mechanism is similar • Strength ([]) vs. Potency (‘oomph’) – Phenothiazines – low potency – Butyrophenones – high potency • Receptor Antagonism – Dopamine2 in brain – Muscarinic cholinergic – Histamine – Norepi at alpha1 Therapeutic effects Uninteded effects
  • 46. Antipsychotic Side Effects Antipsychotic Side Effects Antipsychotic Side Effects • Generally short term • Extrapyramidal symptoms (EPS) • Anticholinergic effects (atropine-like) – Dry mouth, blurred vision, photophobia, tachycardia, constipation) • Orthostatic hypotension • Sedation • Decreased seizure threshold • Sexual dysfunction • Generally short term • Extrapyramidal symptoms (EPS) • Anticholinergic effects (atropine-like) – Dry mouth, blurred vision, photophobia, tachycardia, constipation) • Orthostatic hypotension • Sedation • Decreased seizure threshold • Sexual dysfunction
  • 47. Extrapyramidal Symptoms Extrapyramidal Symptoms Extrapyramidal Symptoms Reaction Onset Features Acute dystonia Hours to 5 days Spasm of tongue, neck, face & back Parkinsonism 5 – 30 days Tremor, shuffling gait, drooling, stooped posture, instability Akathesia 5 – 60 days Compulsive, repetitive motions; agitation Tarditive dyskinesia Months to years Lip-smacking, worm-like tongue movement, ‘fly-catching’
  • 48. Treatment of EPS Treatment of EPS Treatment of EPS • Likely caused by blocking central dopamine2 receptors responsible for movement • Anticholinergic therapy rapidly effective – diphenhydramine (Benadryl®) • Likely caused by blocking central dopamine2 receptors responsible for movement • Anticholinergic therapy rapidly effective – diphenhydramine (Benadryl®)
  • 49. Antipsychotic Agents Antipsychotic Agents Antipsychotic Agents • chlorpromazine (Thorazine®) • thioridazine (Mellaril®) • trifluoperazine (Stelazine®) • haloperidol (Haldol®) • chlorpromazine (Thorazine®) • thioridazine (Mellaril®) • trifluoperazine (Stelazine®) • haloperidol (Haldol®)
  • 50. Antidepressants Antidepressants Antidepressants • Likely cause: inadequate monoamine levels • Treatment options: – Increasing NT synthesis in presynaptic end bulb – Increasing NT release from end bulb – Blocking NT ‘reuptake’ by presynaptic end bulb • Likely cause: inadequate monoamine levels • Treatment options: – Increasing NT synthesis in presynaptic end bulb – Increasing NT release from end bulb – Blocking NT ‘reuptake’ by presynaptic end bulb
  • 51. Tricyclic Antidepressants (TCAs) Tricyclic Tricyclic Antidepressants Antidepressants (TCAs) (TCAs) • Block reuptake of both NE & serotonin – Enhance effects • Similar side effects to phenothiazines • Block reuptake of both NE & serotonin – Enhance effects • Similar side effects to phenothiazines
  • 52. TCA Side Effects TCA Side Effects TCA Side Effects • Orthostatic hypotension • Sedation • Anticholinergic effects • Cardiac toxicity – Ventricular dysrythmias • Orthostatic hypotension • Sedation • Anticholinergic effects • Cardiac toxicity – Ventricular dysrythmias
  • 53. Selective Serotonin Reuptake Inhibitors (SSRIs) Selective Serotonin Reuptake Selective Serotonin Reuptake Inhibitors (SSRIs) Inhibitors (SSRIs) • Block only serotonin (not NE) reuptake – Elevate serotonin levels • Fewer side effects than TCS – No hypotension – No anticholinergic effects – No cardiotoxicity • Most common side effect – Nausea, insomnia, sexual dysfunction • Block only serotonin (not NE) reuptake – Elevate serotonin levels • Fewer side effects than TCS – No hypotension – No anticholinergic effects – No cardiotoxicity • Most common side effect – Nausea, insomnia, sexual dysfunction
  • 54. Monoamine Oxidase Inhibitors (MAOIs) Monoamine Monoamine Oxidase Oxidase Inhibitors Inhibitors ( (MAOIs MAOIs) ) • Monoamine oxidase – Present in liver, intestines & MA releasing neurons – Inactivates monoamines – Inactivates dietary tyramine in liver • Foods rich in tyramine: cheese & red wine • Monoamine oxidase – Present in liver, intestines & MA releasing neurons – Inactivates monoamines – Inactivates dietary tyramine in liver • Foods rich in tyramine: cheese & red wine
  • 55. MAOI Side Effects MAOI Side Effects MAOI Side Effects • CNS Stimulation – Anxiety, agitation • Orthostatic hypotension • Hypertensive Crisis – From increased tyramine consumption • Excessive arteriole constriction, stimulation of heart • CNS Stimulation – Anxiety, agitation • Orthostatic hypotension • Hypertensive Crisis – From increased tyramine consumption • Excessive arteriole constriction, stimulation of heart
  • 56. MAOI & Dietary Tyramine MAOI & Dietary Tyramine MAOI & Dietary Tyramine
  • 58. Antidepressants Agents Antidepressants Agents Antidepressants Agents TCAs • imiprimine (Tofranil®) • amitriptyline (Elavil®) • nortriptyline (Pamelor ®) SSRIs • fluoxetine (Prozac®) • paroxetine (Paxil®) • sertraline (Zoloft®) TCAs • imiprimine (Tofranil®) • amitriptyline (Elavil®) • nortriptyline (Pamelor ®) SSRIs • fluoxetine (Prozac®) • paroxetine (Paxil®) • sertraline (Zoloft®) MAOIs • phenelzine (Nardil®) Atypical Antidepressants • bupropion (Wellbutrin®) MAOIs • phenelzine (Nardil®) Atypical Antidepressants • bupropion (Wellbutrin®)
  • 59. Parkinson’s Disease Parkinson Parkinson’ ’s Disease s Disease • Fine motor control dependent upon balance between excitatory and inhibitory NT – Acetylcholine = excitatory – Dopamine =inhibitory GABA= inhibitory • Fine motor control dependent upon balance between excitatory and inhibitory NT – Acetylcholine = excitatory – Dopamine =inhibitory GABA= inhibitory Control GABA release
  • 61. Parkinson’s Symptoms: Parkinson Parkinson’ ’s Symptoms: s Symptoms: • Similar to EPS • Dyskinesias – Tremors, unsteady gait, instability • Bradykinesia • Akinesia in severe cases • Similar to EPS • Dyskinesias – Tremors, unsteady gait, instability • Bradykinesia • Akinesia in severe cases
  • 62. Parkinson’s Treatment Parkinson Parkinson’ ’s Treatment s Treatment • Dopaminergic approach – ⇑ Release of dopamine – ⇑ [Dopamine] – ⇓ Dopamine breakdown • Cholinergic approach – ⇓ Amount of ACh released – Directly block ACh receptors • All treatment is symptomatic and temporary • Dopaminergic approach – ⇑ Release of dopamine – ⇑ [Dopamine] – ⇓ Dopamine breakdown • Cholinergic approach – ⇓ Amount of ACh released – Directly block ACh receptors • All treatment is symptomatic and temporary
  • 63. Levodopa Levodopa Levodopa • Sinemet ® = levodopa + carbidopa • Increase central dopamine levels • Side effects: – Nausea and vomiting – Dyskinesia (~80% of population) – Cardiovascular (dysrythmias) • Sinemet ® = levodopa + carbidopa • Increase central dopamine levels • Side effects: – Nausea and vomiting – Dyskinesia (~80% of population) – Cardiovascular (dysrythmias)
  • 65. Other Agents Other Agents Other Agents • amantadine (Symmetrel®) – ⇑ release of dopamine from unaffected neurons • bromocriptine (Parlodel®) – Directly stimulated dopamine receptors • selegiline (Carbex®, Eldepryl®) – MAOI selective for dopamine (MAO-B) • benztropine (Cogentin®) – Centrally acting anticholinergic • amantadine (Symmetrel®) – ⇑ release of dopamine from unaffected neurons • bromocriptine (Parlodel®) – Directly stimulated dopamine receptors • selegiline (Carbex®, Eldepryl®) – MAOI selective for dopamine (MAO-B) • benztropine (Cogentin®) – Centrally acting anticholinergic
  • 66. Drugs That Affect the Autonomic Nervous System Drugs That Affect the Drugs That Affect the Autonomic Nervous System Autonomic Nervous System Word of Warning Carefully review the A&P material & tables on pages 309 – 314 and 317 – 321! Word of Warning Carefully review the A&P material & tables on pages 309 – 314 and 317 – 321!
  • 67. PNS Drugs PNS Drugs PNS Drugs • Cholinergic – Agonists & Antagonistis (Anticholinergics) – Based on response at nicotinic(N&M) & muscarinic receptors • Cholinergic – Agonists & Antagonistis (Anticholinergics) – Based on response at nicotinic(N&M) & muscarinic receptors
  • 68. Acetylcholine Receptors Acetylcholine Receptors Acetylcholine Receptors Figure 9-8, page 313, Paramedic Care, V1
  • 69. Cholinergic Agonists Cholinergic Agonists Cholinergic Agonists Salivation Lacrimation Urination Defecation Gastric motility Emesis Salivation Lacrimation Urination Defecation Gastric motility Emesis Cholinergic agents cause SLUDGE! HINT! These effects are predictable by knowing PNS physiology (table 9-4)
  • 70. Direct Acting Cholinergics Direct Acting Direct Acting Cholinergics Cholinergics • bethanechol (Urecholine) prototype – Direct stimulation of ACh receptors – Used for urinary hesitancy and constipation • bethanechol (Urecholine) prototype – Direct stimulation of ACh receptors – Used for urinary hesitancy and constipation
  • 71. Indirect Acting Cholinergics Indirect Acting Indirect Acting Cholinergics Cholinergics • Inhibit ChE (cholinesterase) to prolong the duration of ACh stimulation in synapse • Reversible • Irreversible • Inhibit ChE (cholinesterase) to prolong the duration of ACh stimulation in synapse • Reversible • Irreversible
  • 72. Reversible ChE Inhibitors Reversible ChE Inhibitors Reversible ChE Inhibitors • neostigmine (Prostigmine®) – Myasthenia Gravis at nicotinicM receptors – Can reverse nondepolarizing neuromuscular blockade • physostigmine (Antilirium®) – Shorter onset of action – Used for iatrogenic atropine overdoses @ muscarinic receptors • neostigmine (Prostigmine®) – Myasthenia Gravis at nicotinicM receptors – Can reverse nondepolarizing neuromuscular blockade • physostigmine (Antilirium®) – Shorter onset of action – Used for iatrogenic atropine overdoses @ muscarinic receptors
  • 73. Irreversible ChE Inhibitors Irreversible ChE Inhibitors Irreversible ChE Inhibitors • Very rarely used clinically • Very common in insecticides & chemical weapons – VX and Sarin gas – Cause SLUDGE dammit and paralysis • Tx: atropine and pralidoxime (2-PAM®) – Anticholinergics • Very rarely used clinically • Very common in insecticides & chemical weapons – VX and Sarin gas – Cause SLUDGE dammit and paralysis • Tx: atropine and pralidoxime (2-PAM®) – Anticholinergics
  • 74. Anticholinergics Anticholinergics Anticholinergics • Muscarinic antagonists – Atropine • Ganglionic antagonists – block nicotinicN receptors – Turns off the ANS! – trimethaphan (Arfonad®) • Hypertensive crisis • Muscarinic antagonists – Atropine • Ganglionic antagonists – block nicotinicN receptors – Turns off the ANS! – trimethaphan (Arfonad®) • Hypertensive crisis • Atropine Overdose – Dry mouth, blurred vision, anhidrosis • Atropine Overdose – Dry mouth, blurred vision, anhidrosis Hot as Hell Blind as a Bat Dry as a Bone Red as a Beet Mad as a Hatter Hot as Hell Blind as a Bat Dry as a Bone Red as a Beet Mad as a Hatter
  • 75. Neuromuscular Blockers Neuromuscular Blockers Neuromuscular Blockers • Nicotinic Cholinergic Antagonists – Given to induce paralysis • Depolarizing – succinylcholine (Anectin®) • Nondepolarizing – tubocurarine from curare – rocuronium (Zemuron®) – vecuronium (Norcuron®) • Nicotinic Cholinergic Antagonists – Given to induce paralysis • Depolarizing – succinylcholine (Anectin®) • Nondepolarizing – tubocurarine from curare – rocuronium (Zemuron®) – vecuronium (Norcuron®)
  • 76. Warning! Warning! Warning! • Paralysis without loss of consciousness! – MUST also give sedative-hypnotic – Common agents: • fentanyl (Sublimaze®) • midazolam (Versed®) • Paralysis without loss of consciousness! – MUST also give sedative-hypnotic – Common agents: • fentanyl (Sublimaze®) • midazolam (Versed®)
  • 77. SNS Drugs SNS Drugs SNS Drugs • Predictable response based on knowledge of affects of adrenergic receptor stimulation • HINT: Know table 9-5, page 321 • Each receptor may be: – Stimulated (sympathomimetic) – Inhibitied (sympatholytic) • Predictable response based on knowledge of affects of adrenergic receptor stimulation • HINT: Know table 9-5, page 321 • Each receptor may be: – Stimulated (sympathomimetic) – Inhibitied (sympatholytic)
  • 78. Alpha1 Agonists Alpha Alpha1 1 Agonists Agonists • Profound vasoconstriction – Increases afterload & blood pressure when given systemically – Decreases drug absorption & bleeding when given topically • Profound vasoconstriction – Increases afterload & blood pressure when given systemically – Decreases drug absorption & bleeding when given topically
  • 79. Alpha1 Antagonism Alpha Alpha1 1 Antagonism Antagonism • Inhibits peripheral vasoconstriction – Used for hypertension – prazosin (Minipress®) – doxazosin (Cardura®) – phentolamine (Regitine®) • Blocks alpha1&2 receptors • Inhibits peripheral vasoconstriction – Used for hypertension – prazosin (Minipress®) – doxazosin (Cardura®) – phentolamine (Regitine®) • Blocks alpha1&2 receptors
  • 80. Beta1 Agonists Beta Beta1 1 Agonists Agonists • Increases heart rate, contractility, and conductivity • Increases heart rate, contractility, and conductivity
  • 81. Beta Antagonists (β Blockers) Beta Antagonists ( Beta Antagonists (β β Blockers) Blockers) • Frequently used • Lower Blood Pressure • Negative chronotropes & inotropes • Frequently used • Lower Blood Pressure • Negative chronotropes & inotropes Beta1 Selective Blockade • atenolol (Tenormin®) • esmolol (Brevibloc®) • metoprolol (Lopressor®) Beta1 Selective Blockade • atenolol (Tenormin®) • esmolol (Brevibloc®) • metoprolol (Lopressor®) Nonselective • propranolol (Inderal®) • labetalol (Normodyne®, Trandate®) • sotalol (Betapace®) Nonselective • propranolol (Inderal®) • labetalol (Normodyne®, Trandate®) • sotalol (Betapace®)
  • 82. Adrenergic Receptor Specificity Adrenergic Receptor Specificity Adrenergic Receptor Specificity Drug α1 α2 β1 β2 Dopaminergic Epinephrine Ephedrine Norepinephrine Phenylephrine Isoproterenol Dopamine Dobutamine terbutaline
  • 83. Web Resources Web Resources Web Resources • Web based synaptic transmission project – http://www.williams.edu/imput/index.html • Web based synaptic transmission project – http://www.williams.edu/imput/index.html
  • 84. Thank You! Thank You! Thank You! • To Temple College EMS Professions for permission to use their materials • To Temple College EMS Professions for permission to use their materials